TCL Archive In Brief: Pittsburgh Joins List Of Comprehensive Center Prospect; FDA Schedules Meeting On Cancer Drugs July 11, 1975
TCL Archive Single-Agent Phase III Trial Comparing Vectibix to Erbitux Meets Primary Endpoint May 31, 2013
TCL Archive NCI Plans $30 Million In Patient-Oriented Chemoprevention research In Next 5 Years December 6, 1996
TCL Archive Compendia Publishers Must Tell CMS How They Manage Conflicts Of Interest November 13, 2009